Langerhans cells: Critical regulators of skin immunity

Immunology and Cell Biology

Volumn 88, Issue 4, 2010, Pages 351-360

  Clausen, Björn E ^a   Kel, Junda M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Contact hypersensitivity; Dendritic cell; Interleukin 10; Langerhans cell; Transforming growth factor ; UV radiation

Indexed keywords

INTERLEUKIN 10; LANGERIN; TRANSFORMING GROWTH FACTOR BETA;

CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONTACT ALLERGY; DENDRITIC CELL; GENE TARGETING; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; LANGERHANS CELL; NONHUMAN; REVIEW; SKIN; ULTRAVIOLET RADIATION;

ANIMALS; IMMUNITY; LANGERHANS CELLS; SKIN;

MUS;

EID: 77952220955     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.40     Document Type: Review

References (125)

1. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
2. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007; 37(Suppl 1): S53-S60.
3. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J ExpMed 1973; 137: 1142-1162.
4. Langerhans P. Ueber die Nerven der menschlichen Haut. Virchows Arch 1968; 44: 325-337.
5. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells. In vitro. J Exp Med 1985; 161: 526-546. (Pubitemid 15142803)
6. Wilson NS, Villadangos JA. Lymphoid organ dendritic cells: beyond the Langerhans cells paradigm. Immunol Cell Biol 2004; 82: 91-98.
7. Romani N, Koide S, Crowley M, Witmer-Pack M, Livingstone AM, Fathman CG et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989; 169: 1169-1178.
8. Reise Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993; 178: 509-519.
9. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997; 388: 787-792.
10. Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979; 282: 324-326.
11. Frelinger JG, Hood L, Hill S, Frelinger JA. Mouse epidermal Ia molecules have a bone marrow origin. Nature 1979; 282: 321-323.
12. Stingl G, Katz SI, Clement L, Green I, Shevach EM. Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol 1978; 121: 2005-2013.
13. Pehamberger H, Stingl LA, Pogantsch S, Steiner G, Wolff K, Stingl G. Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNP-modified syngeneic cells: requirement for Ia-positive Langerhans cells. J Invest Dermatol 1983; 81: 208-211.
14. Nishibu A, Ward BR, Jester JV, Ploegh HL, Boes M, Takashima A. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J Invest Dermatol 2006; 126: 787-796.
15. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009; 206: 2937-2946.
16. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993; 361: 82-85.
17. Ohl L, Mohaupt M, Czeloth N, Hintzen G, Kiafard Z, Zwirner J et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004; 21: 279-288.
18. Romani N, Clausen BE, Stoitzner P. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010; 234: 120-141.
19. Brocker T, Riedinger M, Karjalinen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185: 541-550.
20. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411-416.
21. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000; 191: 435-444.
22. Stoitzner P, Pfaller K, Stossel H, Romani N. A close-up view of migrating Langerhans cells in the skin. J Invest Dermatol 2002; 118: 117-125.
23. Hemmi H, Yoshino M, Yamazaki H, Naito M, Iyoda T, Omatsu Y et al. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factorbeta1- dependent cells. Int Immunol 2001; 13: 695-704.
24. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769-779.
25. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196: 1627-1638.
26. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002; 99: 351-358.
27. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, Jiang S et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 2007; 27: 610-624.
28. Wilson NS, El-Sukkari D, Belz GT, Smith CM, Steptoe RJ, Heath WR et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003; 102: 2187-2194.
29. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003; 301: 1925-1928.
30. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006; 25: 153-162.
31. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003; 197: 153-162.
32. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 2005; 174: 2220-2227.
33. Carbone FR, Belz GT, Heath WR. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol 2004; 25: 655-658.
34. He Y, Zhang J, Donahue C, Falo Jr LD. Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 2006; 24: 643-656.
35. Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, Caminschi I et al. Cross-presentation of viral and self antigens by skin-derived CD103(+) dendritic cells. Nat Immunol 2009; 10: 488-495.
36. Randolph GJ. Migratory dendritic cells: sometimes simply ferries? Immunity 2006; 25: 15-18.
37. Moll H, Fuchs H, Blank C, Rö llinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigenspecific T cells. Eur J Immunol 1993; 23: 1595-1601.
38. Will A, Blank C, Rö llinghoff M, Moll H. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. Eur J Immunol 1992; 22: 1341-1347.
39. Ritter U, Meissner A, Scheidig C, Körner H. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 2004; 34: 1542-1550.
40. Brewig N, Kissenpfennig A, Malissen B, Veit A, Bickert T, Fleischer B et al. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol 2009; 182: 774-783.
41. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. A natural model of Leishmania major infection reveals a prolonged 'silent' phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 2000; 165: 969-977.
42. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
43. Pulendran B, Tang H, Denning TL. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr Opin Immunol 2008; 20: 61-67.
44. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12: 71-81.
45. Birbeck MS, Breathnach AS, Everall JD. An electron microscopic study of basal melanocytes and high level clear cells (Langerhans cell) in vitiligo. J Invest Dermatol 1961; 37: 51-64.
46. de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007; 13: 367-371.
47. Stoitzner P, Holzmann S, McLellan AD, Ivarsson L, Stössel H, Kapp M et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 2003; 120: 266-274.
48. Valladeau J, Duvert-Frances V, Pin JJ, Dezutter-Dambuyant C, Vincent C, Massacrier C et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999; 29: 2695-2704.
49. Valladeau J, Clair-Moninot V, Dezutter-Dambuyant C, Pin JJ, Kissenpfennig A, Mattéi MG et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 2002; 168: 782-792.
50. Takahara K, Omatsu Y, Yashima Y, Maeda Y, Tanaka S, Iyoda T et al. Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 2002; 14: 433-444.
51. Saito M, Iwawaki T, Taya C, Yonekawa H, Noda M, Inui Y et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol 2001; 19: 746-750.
52. Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69: 1051-1061.
53. Mitamura T, Umata T, Nakano F, Shishido Y, Toyoda T, Itai A et al. Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis. J Biol Chem 1997; 272: 27084-27090.
54. Bennett CL, Clausen BE. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol 2007; 28: 525-531.
55. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002; 17: 211-220.
56. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169: 569-576.
57. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhé C, Perrin P, Romani N et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005; 22: 643-654.
58. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005; 23: 611-620.
59. Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, Wunderlich FT et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2005; 2: 419-426.
60. Brockschnieder D, Pechmann Y, Sonnenberg-Riethmacher E, Riethmacher D. An improved mouse line for Cre-induced cell ablation due to diphtheria toxin A, expressed from the Rosa26 locus. Genesis 2006; 44: 322-327.
61. Rajewsky K, Gu H, Kühn R, Betz UA, Mü ller W, Roes J et al. Conditional gene targeting. J Clin Invest 1996; 98: 600-603. (Pubitemid 26349161)
62. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. Autocrine/ paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med 2007; 204: 2545-2552.
63. Caton ML, Smith-Raska MR, Reizis B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med 2007; 204: 1653-1664.
64. Sullivan S, Bergstresser PR, Tigelaar RE, Streilein JW. Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol 1986; 137: 2460-2467.
65. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH et al. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 2007; 204: 3147-3156.
66. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, Malissen B. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007; 204: 3119-3131.
67. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J ExpMed 2007; 204: 3133-3146.
68. Nagao K, Ginhoux F, Leitner WW, Motegi S, Bennett CL, Clausen BE et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci USA 2009; 106: 3312-3317.
69. Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, de Bovis B et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2010; 207: 189-206. S1-6.
70. Kaplan DH, Kissenpfennig A, Clausen BE. Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 2008; 38: 2369-2376.
71. Noordegraaf M, Flacher V, Stoitzner P, Clausen BE. Functional redundancy of Langerhans cells and Langerin+ dermal dendritic cells in contact hypersensitivity. 2010 (submitted).
72. Bennett CL, Noordegraaf M, Martina CA, Clausen BE. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol 2007; 179: 6830-6835.
73. Stoitzner P, Stingl G, Merad M, Romani N. Langerhans cells at the interface of medicine, science, and industry. J Invest Dermatol 2010; 130: 331-335.
74. Bacci S, Alard P, Dai R, Nakamura T, Streilein JW. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity. Eur J Immunol 1997; 27: 442-448.
75. Stoitzner P, Green LK, Jung JY, Price KM, Tripp CH, Malissen B et al. Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J Immunol 2008; 180: 1991-1998.
76. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980; 124: 445-453.
77. Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009; 206: 549-559.
78. Obhrai JS, Oberbarnscheidt M, Zhang N, Mueller DL, Shlomchik WD, Lakkis FG et al. Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol 2008; 128: 1950-1955.
79. Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 2004; 10: 510-517.
80. Stoitzner P, Tripp CH, Douillard P, Saeland S, Romani N. Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation. J Invest Dermatol 2005; 125: 116-125.
81. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci USA 1997; 94: 11-14.
82. Aberer W, Schuler G, Stingl G, Honigsmann H, Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981; 76: 202-210.
83. Elmets CA, Bergstresser PR, Tigelaar RE, Wood PJ, Streilein JW. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med 1983; 158: 781-794.
84. Schwarz T. 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol 2008; 84: 10-18.
85. Schwarz A, Maeda A, Kernebeck K, van Steeg H, Beissert S, Schwarz T. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J Exp Med 2005; 201: 173-179.
86. Schwarz A, Noordegraaf M, Maeda A, Torii K, Clausen BE, Schwarz T. Langerhans cells are required for UVR-Induced immunosuppression. J Invest Dermatol 2010. (doi 10.1038/jid.2009.429).
87. Wang L, Jameson SC, Hogquist KA. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J Immunol 2009; 183: 5548-5553.
88. Kölgen W, van Steeg H, van der Horst GT, Hoeijmakers JH, van Vloten WA, de Gruijl FR et al. Association of transcription-coupled repair but not global genome repair with ultraviolet-B-induced Langerhans cell depletion and local immunosuppression. J Invest Dermatol 2003; 121: 751-756.
89. Schwarz A, Maeda A, Schwarz T. Alteration of the migratory behavior of UV-induced regulatory T cells by tissue-specific dendritic cells. J Immunol 2007; 178: 877-886.
90. Mehling A, Loser K, Varga G, Metze D, Luger TA, Schwarz T et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 2001; 194: 615-628.
91. Seery JP, Carroll JM, Cattell V, Watt FM. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med 1997; 186: 1451-1459.
92. Schwarz T, Schwarz A. DNA repair and cytokine responses. J Investig Dermatol Symp Proc 2009; 14: 63-66.
93. Glaser R, Navid F, Schuller W, Jantschitsch C, Harder J, Schröder JM et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 2009; 123: 1117-1123.
94. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993; 90: 770-774.
95. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
96. Leveen P, Larsson J, Ehinger M, Cilio CM, Sundler M, Sjöstrand LJ et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002; 100: 560-568.
97. Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006; 25: 441-454.
98. Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000; 12: 171-181.
99. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006; 24: 99-146.
100. Karlsson G, Liu Y, Larsson J, Goumans MJ, Lee JS, Thorgeirsson SS et al. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling. Physiol Genomics 2005; 21: 396-403.
101. Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, Brousse N et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999; 162: 4567-4575.
102. Ohtani T, Mizuashi M, Nakagawa S, Sasaki Y, Fujimura T, Okuyama R et al. TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 2009; 126: 485-499.
103. Torres-Aguilar H, Aguilar-Ruiz SR, Gonzalez-Perez G, Mungúa R, Bajaña S, Meraz-Ŕos MA et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol 2010; 184: 1765-1775.
104. Fainaru O, Shay T, Hantisteanu S, Goldenberg D, Domany E, Groner Y. TGFbetadependent gene expression profile during maturation of dendritic cells. Genes Immun 2007; 8: 239-244.
105. Faunce DE, Terajewicz A, Stein-Streilein J. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J Immunol 2004; 172: 1991-1995.
106. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J ExpMed 1996; 184: 2417-2422.
107. Borkowski TA, Letterio JJ, Mackall CL, Saitoh A, Wang XJ, Roop DR et al. A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J Clin Invest 1997; 100: 575-581.
108. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl C et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003; 4: 380-386.
109. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004; 23: 969-979.
110. Thomas RM, Belsito DV, Huang C, Chen LZ, Ormsby I, Simmons WJ et al. Appearance of Langerhans cells in the epidermis of Tgfb1 SCID mice: paracrine and autocrine effects of transforming growth factor-beta 1 and -beta 2. J Invest Dermatol 2001; 117: 1574-1580.
111. Kel JM, Noordegraaf M, Girard-Madoux MJH, Reizis B, Clausen BE. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. 2010 (submitted).
112. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
113. Kühn R, Lohler J, Rennick D, Rajewsky K, Mü ller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
114. Spencer SD, Di Marco F, Hooley J, Pitts-Meek S, Bauer M, Ryan AM et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 1998; 187: 571-578.
115. Roers A, Siewe L, Strittmatter E, Deckert M, Schlü ter D, Stenzel W et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med 2004; 200: 1289-1297.
116. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28: 546-558.
117. Siewe L, Bollati-Fogolin M, Wickenhauser C, Krieg T, Mü ller W, Roers A. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur J Immunol 2006; 36: 3248-3255.
118. Pils MC, Pisano F, Fasnacht N, Heinrich JM, Groebe L, Schippers A et al. Monocytes/ macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur J Immunol 2010; 40: 443-448.
119. Steinbrink K, Jonuleit H, Mü ller G, Schuler G, Knop J, Enk AH. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 1999; 93: 1634-1642.
120. Mü ller G, Mü ller A, Tü ting T, Steinbrink K, Saloga J, Szalma C et al. Interleukin-10- treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J Invest Dermatol 2002; 119: 836-841.
121. Perona-Wright G, Anderton SM, Howie SE, Gray D. IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease. Int Immunol 2007; 19: 1123-1134.
122. Lan YY, Wang Z, Raimondi G, Wu W, Colvin BL, de Creus A et al. 'Alternatively activated' dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 2006; 177: 5868-5877.
123. Berg DJ, Leach MW, Kühn R, Rajewsky K, Mü ller W, Davidson NJ et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995; 182: 99-108.
124. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8: 1095-1104.
125. Igyarto BZ, Jenison MC, Dudda JC, Roers A, Mü ller W, Koni PA et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol 2009; 183: 5085-5093.